Pharma Journalist - Page 847 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

Provention Bio Announces Licensing Agreements with Janssen for Two Clinical-Stage Immunology Assets

Chemotherapy pain could be eased by jetlag drug, study suggests

AstraZeneca and Aspen enter agreement for remaining rights to anaesthetics medicines

NUS scientists combine antimalarial drug with light sensitive molecules for promising treatment of cancer

Immunocore and the Bill & Melinda Gates Foundation Collaborate to Develop Immunotherapies for Infectious Diseases

Regeneron and Sanofi Announce Positive Study Results for DUPIXENT

TSI Completes Phase 1 Clinical Trial of Novel Clot-dissolving Therapy, TS01

Eurofins to expand its presence in North America with the acquisition of EAG Laboratories

Absorption Systems Embarks on Research Collaboration with the U.S. FDA

Arcus Biosciences Announces Option and License Agreement with Taiho Pharmaceutical